For Dementia Action Week on International Clinical Trials Day 2019, a unique research group has been launched to test promising new drugs for dementia, including one of the world’s first studies with an antidepressant that could stop the disease progressing. Cambridgeshire and Peterborough NHS Foundation Trust has partnered with the University of Cambridge to set […]
Structural brain changes in schizophrenia are associated with brain expression of schizophrenia related genes
Psychotic disorders have a lifetime prevalence of up to three percent and can be extremely debilitating However, despite significant efforts, the brain architectural changes and biological mechanisms causing psychotic disorders are not yet well understood, and there has been correspondingly limited progress in the development of new therapeutics. New research by Dr Sarah Morgan looks […]
100 years since Nijinsky met Bleuler
100 years since Nijinsky met Bleuler: Can we still learn from individual cases? In this interview with CPFT consultant psychiatrist Dr Emilio Fernandez-Egea, clinical lecturer Dr Muzaffer Kaser asks what the Nijinsky case can teach us about the origins and development of schizophrenia. This interview follows Emilio’s talk for CPFT and the University of […]
Inflammation links heart disease and depression, study finds
People with heart disease are more likely to suffer from depression, and the opposite is also true. Now, scientists at the University of Cambridge believe they have identified a link between these two conditions: inflammation – the body’s response to negative environmental factors, such as stress. “It is possible that heart disease and depression share […]
- 1
- 2
- 3
- …
- 12
- Next Page »